Article

BRAFV600E testing for low-risk papillary thyroid microcarcinomas -- Computational model from a patient-oriented approach

2022-09-08

Abstract excerpt

<h4>Background: </h4> Given the good prognosis of low-risk papillary thyroid microcarcinomas (lrPTMCs) accurate risk stratification is valuable to optimize management: active surveillance vs. surgery. BRAFV600E testing was associated with increased recurrence risk, hence AS seems reasonable for mutation-negative lrPTMC. However, when considering AS, patient perception is highly important as adherence and emotional...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7fbcfb2a-410e-5aae-bbeb-9a96fbced6e9
DOI: 10.22541/au.166260783.37386975/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

BRAFV600E testing for low-risk papillary thyroid microcarcinomas -- Computational model from a patient-oriented approachDOI 10.22541/au.166260783.37386975/v1Read

Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies.Semantic proximity Read

BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk ManagementSemantic proximity Read

BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.Semantic proximity Read

BRAF V600E mutation in papillary thyroid microcarcinoma: is it a predictor for the prognosis of patients with intermediate to high recurrence risk?Semantic proximity Read

BRAF Mutation and Tumor Growth Kinetics during Active Surveillance of Papillary Thyroid Microcarcinoma: A Single-Center Retrospective Study.Semantic proximity Read

Risk factors associated with aggressive tumor phenotypes in papillary thyroid microcarcinoma: a systematic review and meta-analysis.Semantic proximity Read

BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients.Semantic proximity Read

Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.Semantic proximity Read

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.Semantic proximity Read

BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm.Semantic proximity Read

[Assessing BRAF status of localized and locally advanced papillary thyroid microcarcinomas using machine learning methods].Semantic proximity Read

The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?Semantic proximity Read